Back to News
Market Impact: 0.2
Wall Street Analysts Think Foghorn Therapeutics (FHTX) Could Surge 67.01%: Read This Before Placing a Bet
Source: zacks.com
Analyst EstimatesAnalyst InsightsInvestor Sentiment & PositioningCompany Fundamentals
Foghorn Therapeutics (FHTX) has a consensus price target implying ~67% upside, though the article notes this metric is not highly predictive. The near-term bullish catalyst is an upward trend in earnings estimate revisions, which could support the stock if revisions continue. Overall, sentiment is mildly positive but framed as uncertain.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.18
Ticker Sentiment
FHTX0.25
More News
- Can Estee Lauder's Innovation Push Unlock the Next Growth Wave?
- Nvidia GPUs are everywhere. Here are the ways companies are accessing them
- Bank of America is bullish on these top stocks ahead of earnings
- Stocks were up this week. Here are the names that are now overbought
- As companies pour billions into Earth-based AI infrastructure, Google is taking the data center race off-planet
- How U.S. know-how is fracking Australia into a gas boom, from Texas oilmen to Trump’s energy secretary